SBS:ETR
Stratec SE
€ 23.45
0.00%
(0.00) Siku 1
12 Okt, 17:35:17 GMT +2 · EUR
search
Alama zote
| Alama | Bei | Tofauti | Tofauti ya asilimia |
|---|
insights_autoInatayarisha maarifa maarufu ya SBS...
Mtaji wa soko
285.10M
Wastani wa kiasi cha mauzo
elfu 13.70
Kiasi cha mauzo ya hisa
0.00
Gawio
2.56%
Mgawo wa faida wa kila robo mwaka
€ 0.15
Tarehe ya kutojumuisha gawio
24 Jun 2026
Juu kwa wiki 52
€ 29.50
Chini kwa wiki 52
€ 16.30
EPS
-€ 0.03
Hisa za wawekezaji
12.16M
Idadi ya wafanyakazi
elfu 1
Mtaji wa soko
285.10M
Wastani wa kiasi cha mauzo
elfu 13.70
Kiasi cha mauzo ya hisa
0.00
Gawio
2.56%
Mgawo wa faida wa kila robo mwaka
€ 0.15
Tarehe ya kutojumuisha gawio
24 Jun 2026
Juu kwa wiki 52
€ 29.50
Chini kwa wiki 52
€ 16.30
EPS
-€ 0.03
Hisa za wawekezaji
12.16M
Idadi ya wafanyakazi
elfu 1
Habari
Kutoka kwenye vyanzo vya wavuti na washirika wa habari
ad-hoc-news.de
·
saa 2 zilizopita
mwb research downgraded Stratec stock to Sell at EUR 21.00 target
Wasifu
STRATEC SE is a company with worldwide operations that designs and manufactures fully automated analyzer systems for partners in clinical diagnostics and biotechnology - particularly in the field of in-vitro-diagnostics.
As a classic original equipment manufacturer supplier, STRATEC produces its systems almost exclusively on behalf of its customers. Alongside the systems themselves, the company also provides sample preparation solutions, system software and integrated laboratory software. STRATEC is also responsible for development documentation, testing, delivery of systems, and the supply of spare parts and complex consumables for diagnostic and medical applications. STRATEC's customers are well known diagnostic companies like DiaSorin, Abbott, SIEMENS, Bio-Rad or Hologic. Wikipedia
Kuhusu Stratec SE